Breaking AI & Tech News Analyzed

Trump’s Public Endorsement of Psychedelic TherapiesIn a recent Guardian podcast, Donald Trump signaled support for scientific studies into psychedelic compounds, asking, “Can I have some, please?” while framing the conversation as a potential public‑health breakthrough.Funding Landscape and Recent Regulatory Milestones2023: The U.S. Food and Drug Administration granted breakthrough‑therapy designation to psilocybin for treatment‑resistant depression.2024: The National Institute on Drug Abuse allocated $150 million to clinical trials of MDMA‑assisted psychotherapy.2025: Several states, including Oregon and Colorado, legalized psilocybin for therapeutic use, creating a nascent market valued at roughly $2 billion.Potential Shift in Federal Drug PolicyTrump’s backing could influence congressional committees that oversee the Drug Enforcement Administration and the FDA. A high‑profile endorsement may:Accelerate bipartisan bills aimed at de‑scheduling certain psychedelics.Encourage the administration to prioritize research funding in upcoming budget proposals.Prompt the White House to convene a task force on psychedelic medicine.Impact on Mental‑Health Treatment ParadigmsShould policy changes follow, clinicians could gain broader access to psychedelic‑assisted therapies, potentially reducing reliance on traditional antidepressants. This aligns with growing evidence that psychedelics can produce rapid, sustained improvements for conditions such as PTSD and major depressive disorder.Looking Ahead: Political and Clinical OutlookAnalysts anticipate that Trump’s endorsement will keep psychedelics on the national agenda through the 2026 midterm elections. If legislative momentum continues, the United States could see:A federal framework for clinical trials by 2027.Expanded insurance coverage for approved psychedelic treatments by 2028.Increased private‑sector investment, potentially adding $5 billion to the market over the next five years.

The deployment of reflective mirrors on satellites and the launch of thousands more satellites into low Earth orbit could have significant consequences for human health and ecosystems. Leading sleep and circadian rhythm researchers have raised concerns about the potential disruption to natural night-time light environments.The US Federal Communications Commission (FCC) is considering plans by Reflect Orbital to illuminate parts of the Earth at night using reflective satellites, as well as applications from SpaceX that could dramatically expand satellite numbers in low Earth orbit.2,500 researchers from over 30 countries have expressed concerns that altering the light-dark cycle could disrupt biological clocks that regulate sleep and hormone secretion in humans and animals, migration in nocturnal species, seasonal cycles in plants, and the rhythms of marine phytoplankton.Prof Charalambos Kyriacou, president of the European Biological Rhythms Society (EBRS), emphasized that "plants need the night" and that eliminating it could have global implications for food security.Reflect Orbital aims to use satellites equipped with large reflective mirrors to redirect sunlight onto areas roughly 5km to 6km wide "on demand", with brightness adjustable "from full moon to full noon".Meanwhile, SpaceX has proposed launching up to 1m satellites to create a giant solar-powered computing network in orbit designed to run artificial-intelligence workloads.Ruskin Hartley, chief executive of DarkSky International, noted that scientific studies have already shown that the existing number of satellites in orbit has increased diffuse night sky brightness by roughly 10%.Experts warn that if current trends in satellite launches and debris generation continue, night sky brightness could increase substantially over the coming decade, approaching the threshold astronomers have set for preserving naturally dark skies.

The United States Supreme Court issued an 8‑1 decision on Tuesday that invalidated Colorado’s law prohibiting “conversion therapy” for LGBTQ minors. The majority held that the ban infringed on the First Amendment’s free‑speech guarantees, arguing that even therapeutic dialogue falls under protected expression. Justice Elena Kagan wrote that when a state suppresses one side of a debate while supporting the other, the constitutional issue is “straightforward.” In contrast, Justice Neil Gorsuch emphasized that the First Amendment “stands as a shield against any effort to enforce orthodoxy in thought or speech.” Only Justice Ketanji Brown Jackson dissented, warning that the ruling “threatens to impair states’ ability to regulate the provision of medical care” and underscored the documented harms of conversion therapy to LGBTQ youth. Colorado’s 2019 statute barred any “practice or treatment” aimed at changing a child’s gender identity or sexual orientation, though it allowed discussion of religion, gender, and sexuality. No individual has yet been sanctioned under the law. The case was brought by Christian counselor Kaley Chiles, who argued that the ban prevented her from offering voluntary, faith‑based talk therapy, a position backed by the administration of former President Donald Trump. Approximately two dozen states have enacted similar bans, reflecting a growing consensus that conversion therapy is both ineffective and harmful. Scientific studies link the practice to higher rates of depression and suicidal ideation among LGBTQ individuals. Major medical associations have condemned it as a dangerous, discredited intervention. Advocates for LGBTQ rights criticized the Court’s ruling as a setback. Polly Crozier, director of family policy at GLAD Law, said, “This is a dangerous practice that has been condemned by every major medical association in the country. Today’s decision does not change the science, and it does not change the fact that conversion therapists who harm patients will still face legal consequences.” The decision is expected to make enforcement of existing bans more difficult, potentially prompting a wave of legal challenges in other jurisdictions that have sought to protect LGBTQ youth from conversion therapy.